'Lifeline' neonatal service in the North East is saved by new funding
A neonatal unit hailed as a 'lifeline' in the North East has been saved by new vital funding after facing an uncertain future due to financial difficulties.
Leo's Neonatal, the only dedicated neonatal trauma support service in the region, has received backing from law firm Slater and Gordon.
The Teesside-based charity, which supports the mental health and wellbeing of families affected by neonatal trauma, had been at risk of reducing its services due to a drop in funding and donations.
(Image: LEO'S NEONATAL CHARITY) Founded in 2018, Leo's provides therapies such as Eye Movement Desensitisation and Reprocessing (EMDR), trauma-focused talking therapies, Flash and Cognitive Behavioural Therapy (CBT).
The charity has thousands of contacts with families across the North East each year and has seen increasing demand, with a 100 percent referral rate for mental health support from clinical staff.
However, due to a drop in funding and donations, Leo's was forced to consider the future of some of its services – including its neonatal trauma support, which is the only dedicated service of its kind in the region, offering specialist lived experience mentoring and targeted trauma interventions.
(Image: LEO'S NEONATAL CHARITY) Leo's founder and CEO, Lottie King, said losing the trauma support service would have been devastating for parents facing grief and trauma.
Lottie established the charity in memory of her son, Leo, who died shortly after birth in 2015. His twin, Oska, was in the Special Care Baby Unit at North Tees Hospital for over 100 days after being born four days later.
Now, law firm Slater and Gordon has partnered with Leo's – which received a Points of Light award from then-Prime Minister Boris Johnson for its life-changing impact – to deliver the funding to enable its specialist support for families in need to continue.
Lottie said: 'Our neonatal trauma service has proved a lifeline to so many parents and it would have been absolutely devastating if we had to close.
'The need for specialist support for neonatal parents who have been impacted by grief and trauma is massive and increasing all the time, and it doesn't bear thinking about if we had to turn them away.
"In addition to the huge pressure on NHS resources and long waiting lists for mental health support, there is no guarantee parents affected by neonatal trauma will be able to see a specialist – and at Leo's, our team know through their own lived experience how vital it is that specialist support is available."
READ MORE:
Fight for charity helping sick babies in North East
UK's first Neonatal Mental Health Awareness Week launched by Leo's
Baby's hearts to beat on forever with Leo's 'heartbeat bears'
John Lowther, senior associate at Slater and Gordon in Newcastle, said: 'Leo's Neonatal has supported countless families across our region during some of their darkest days, and demand for their services is growing all the time.
"This charity was born out of lived experience and has identified a range of areas in which specialist therapies, support and interventions can positively impact the lives of parents and children at times when they need it most.
'We are really delighted to partner with Lottie and her amazing team, and to be able to give our backing to the dedicated neonatal trauma support service, which we know plays such a critical role in the mental health of so many parents.
"Knowing the impact of this service, and the growing demand Leo's faces to deliver it, its closure is unthinkable. We are so pleased we can help them to continue their life-changing work.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Opterion Health AG Appoints Industry Leaders Rice Powell and Mark Hahn to Board of Directors
MUTTENZ, Switzerland, June 23, 2025 (GLOBE NEWSWIRE) -- Opterion Health AG, a Swiss-based life sciences company developing a next-generation, non-glucose based peritoneal dialysis (PD) solution, today announced the appointment of two highly accomplished executives to its Board of Directors: Rice Powell, former Chairman and CEO of Fresenius Medical Care, and Mark Hahn, Chief Financial Officer of Verona Pharma and a veteran biotech finance leader. These appointments represent a significant step forward in the strategic development of Opterion Health as it prepares for clinical trials and future commercialization. Rice Powell and Mark Hahn have demonstrated decades of leadership in renal care, biotechnology, and corporate strategy, reinforcing the company's commitment to innovation and improving patient outcomes. Rice Powell brings more than 30 years of experience in the global dialysis and healthcare industry. As Chairman and CEO of Fresenius Medical Care, he led the world's largest provider of dialysis products and services through a decade of strategic transformation and international growth. His leadership was instrumental in expanding access to renal therapies and improving standards of care across continents. Rice Powell, Former Chairman and CEO of Fresenius Medical Care 'The mission of Opterion Health to transform peritoneal dialysis resonates deeply with me,' said Rice Powell. 'Having spent my career focused on renal care, I see tremendous potential in this approach to improving quality of life for patients. I'm honored to support the company's vision and contribute to its strategic direction.' Mark Hahn brings over two decades of financial leadership in the life sciences sector. Currently serving as CFO of Verona Pharma, he has played a central role in fundraising, IPO execution, and scaling operations in both private and public biotech companies. His previous roles include CFO positions at Dova Pharmaceuticals, Cempra, and Athenix, where he consistently delivered financial strategy aligned with corporate growth. Mark Hahn, Chief Financial Officer of Verona Pharma Mark Hahn also works closely with David Ebsworth, Chairman of Opterion Health, at Verona Pharma. Their ongoing collaboration and shared experience navigating complex financial and regulatory environments will be instrumental as Opterion Health advances its clinical and commercial roadmap. 'Opterion Health is at a truly exciting inflection point,' said Mark Hahn. 'The science is compelling, the leadership is visionary, and the opportunity to make a real difference in patients' lives is profound. I'm excited to help guide the company's financial and strategic growth.' David Ebsworth commented: 'Welcoming Rice and Mark to our Board is a major milestone for Opterion Health. Rice's unparalleled leadership in renal care and Mark's deep financial expertise bring extraordinary strength to our governance. Their insights and experience will be invaluable as we move toward clinical trials and beyond. I am more confident than ever in the company's future.' About Opterion Health AGOpterion Health is developing a novel peritoneal dialysis (PD) solution aimed at revolutionizing the dialysis market. Backed by leading life science investors, the company is headquartered in the Basel area, the pharmaceutical heart of Switzerland, and supported by a strong team of scientists, entrepreneurs, and nephrologists across Europe. Find us at: Photos accompanying this announcement are available at: For more information or to contact us, please email info@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
New York Post
a day ago
- New York Post
Nationwide recall issued for popular chocolate brand that contains potentially ‘life-threatening' ingredient
A popular chocolate treat is being pulled from shelves nationwide over an ingredient that may trigger severe – and potentially deadly – allergic reactions, federal officials warned. An urgent recall was issued after Lipari Foods discovered that its 14-ounce packages of JLM Branded Dark Chocolate Nonpareils may contain undeclared milk, the US Food and Drug Administration (FDA) announced Friday. Those with milk allergies are urged to avoid consuming the potentially lethal candy. Select packages of JLM Branded Dark Chocolate Nonpareils may contain undeclared milk. USFDA 'People who have allergies to milk run the risk of serious or life-threatening allergic reactions if they consume these products,' the dire bulletin stated. The Michigan-based company initiated the recall after its distributor, Weave Nut Company, alerted them that the candy may contain the dairy allergen, which was not disclosed on the packaging. But the sprinkle-topped chocolate discs, sold in clear plastic tubs, had already made their way to retailers across the country. The recall targets packaging with lot codes 28202501A, 29202501A, 23202504A, 14202505A, 15202505A, and 03202506A on the bottom label. No illnesses or adverse reactions have been reported in connection with the recall. Brent Hofacker – The FDA advised customers to return the product to the place of purchase for a full refund. No illnesses or adverse reactions have been reported in connection with the recall.
New York Post
a day ago
- New York Post
Grieving parents awarded $2.25M after Georgia doctor plastered videos of their decapitated baby on social media
A Georgia couple whose baby was decapacitated during childbirth was awarded a $2.25 million verdict after their pathologist posted graphic autopsy videos on social media without their consent. Dr. Jackson Gates and his Atlanta-based business will have to fork over the large sum to Jessica Ross and Traveon Taylor Sr. after a Fulton County jury found him liable of emotional distress, invasion of privacy, and fraud on Wednesday. 'This young couple trusted him with the remains of their precious baby,' attorney's for the grieving parents said, noting that the doctor 'poured salt into the couple's already deep wounds.' 3 Jessica Ross and Treveon Taylor Sr., parents of a baby who was decapitated during childbirth. AP 'Gates, in turn, repaid this trust by posting horrific images of their child for the world to see.' The heartbroken couple hired the twisted doctor to perform an autopsy on their deceased newborn two days after their obstetrician allegedly applied excessive force to the baby's neck when its shoulders became stuck in Ross's pelvic area, causing it to detach during the traumatic July 2023 delivery. 3 The traumatic delivery occurred at Southern Regional Medical Center in July 2023. ERIK S LESSER/EPA-EFE/Shutterstock The baby's head was delivered vaginally, but the rest of the body was removed via C-section. The death was later ruled a homicide. Gates posted numerous videos and photos to his Instagram later that month, showing the grisly postmortem examination of their infants 'decapitated, severed head,' the couple said in their lawsuit. The deranged pathologist initially removed the footage after receiving a letter from the couple's attorney — but later reposted them, according to the lawsuit. 3 The couple was awarded $2.25 million in a lawsuit against their pathologist. AP Gates' attorney, Ira Livant, said his client typically documents his autopsy's on social media to educate fellow pathologists and highlight the importance of independent examinations in cases where families suspect medical misconduct. 'Dr. Gates testified that he is deeply sorry for any harm that he unintentionally caused the plaintiffs,' Livant said Saturday. 'Had he known for one second that they would see that and that they would know it was their child, he would never have done it.' The couple will receive $2 million in compensatory damages and an additional $250,000 in punitive damages from Gates and his company, Medical Diagnostics Choices, per the judgement. The bereaved parents have separate lawsuits pending against the delivering doctor and the Riverdale hospital where the horrific incident took place. With Post wires.
